Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04298827 · ClinicalTrials.gov registry record · NA

Gyn Onc Prehab Study

A NA study, sponsored by St. Louis University.

Completed
Registry status
NA
Development phase
83
Enrollment target

NCT04298827: Completed NA study, sponsored by St. Louis University.

NCT04298827 is a NA study that has completed, run by St. Louis University. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04298827, a NA study, has completed, sponsored by St. Louis University.

COMPLETED
Registry status
NA
Development phase
83 participants
Enrollment target

Study Summary

Patients will be randomized to a unimodal or trimodal prehabilitation program prior to surgery for known or suspected gynecologic cancer.

Primary Outcome

Patients will have a preoperative physical therapy assessment incorporating standard evaluations of a 6 minute walk test, grip strength, and timed up and go. These will serve as the individual patient's baseline for subsequent comparison after surgery.

Interventions

  • OTHER Unimodal
  • OTHER Trimodal

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2020-07-21
Est. Completion 2024-03-01
Phase NA
St. Louis University

107 total trials

What the finished NCT04298827 record still lists

NCT04298827 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Unimodal is the first listed.

NCT04298827 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04298827 about?

NCT04298827 is a clinical study titled "Gyn Onc Prehab Study". Patients will be randomized to a unimodal or trimodal prehabilitation program prior to surgery for known or suspected gynecologic cancer.

What is the current status of trial NCT04298827?

This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2020-07-21. Estimated completion is 2024-03-01.

What interventions are being tested in trial NCT04298827?

The interventions under investigation include: Unimodal (OTHER), Trimodal (OTHER).

Who is sponsoring clinical trial NCT04298827?

This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04298827's enrollment target sits among peer trials

83 990th of 2000 higher than 1,011 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02974647 · 83 participants · Phase 2

    Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

  • NCT03919292 · 83 participants · Phase 1

    Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

  • NCT04626674 · 83 participants · Phase 1

    A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

  • NCT05277168 · 83 participants · Phase 1

    A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04298827, the US trial registry maintained by the National Library of Medicine. NCT04298827 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.